Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Driehaus Micro Cap Growth DMCRX
- NAV / 1-Day Return 11.52 / −1.20 %
- Total Assets 240.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.420%
- Distribution Fee Level High
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Limited
- TTM Yield 0.77%
- Turnover 128%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 12:05 AM GMT+0
Morningstar’s Analysis DMCRX
Will DMCRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Modine Manufacturing Co | 3.10 | 7.5 Mil | Consumer Cyclical |
Crinetics Pharmaceuticals Inc | 2.70 | 6.5 Mil | Healthcare |
Camtek Ltd | 2.40 | 5.8 Mil | Technology |
Xenon Pharmaceuticals Inc | 2.19 | 5.3 Mil | Healthcare |
FTAI Aviation Ltd | 1.94 | 4.7 Mil | Industrials |
Sterling Infrastructure Inc | 1.81 | 4.4 Mil | Industrials |
Rhythm Pharmaceuticals Inc | 1.63 | 3.9 Mil | Healthcare |
Vaxcyte Inc Ordinary Shares | 1.54 | 3.7 Mil | Healthcare |
Uranium Energy Corp | 1.52 | 3.7 Mil | Energy |
Blue Bird Corp | 1.48 | 3.6 Mil | Consumer Cyclical |